Wall Street Associates’s Evolent Health EVH Stock Holding History

Wall Street Associates’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.66M	Sell	112,449 -94,251	-46%	-$1.86M	1.1%	17
2016 Q3	$5.09M	Buy	206,700 +30,000	+17%	+$701K	1.73%	1
2016 Q2	$3.39M	Buy	176,700 +38,900	+28%	+$534K	1.36%	10
2016 Q1	$1.46M	Hold	137,800	–	–	0.6%	69
2015 Q4	$1.67M	Sell	137,800 -50,800	-27%	-$749K	0.47%	69
2015 Q3	$3.01M	Sell	188,600 -177,000	-48%	-$3.45M	0.58%	56
2015 Q2	$7.13M	Buy	+365,600	New	+$6.82M	0.67%	50

Other funds holding EVH

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Wall Street Associates's EVH Position: Q4 2016 in Review

Wall Street Associates reduced its Evolent Health (EVH) stake by 46% in Q4 2016, selling an estimated $1.86M and leaving 112,449 shares worth $1.66M. The position accounts for 1.1% of the portfolio, ranked #17.

Wall Street Associates first reported a position in EVH in Q2 2015 and has held it in 7 quarters since. The position peaked at $7.13M in Q2 2015. 118 funds tracked by Wall St. Rank hold EVH as of Q4 2016.

Wall Street Associates held 112,449 shares of Evolent Health worth $1.66M as of Q4 2016.
Wall Street Associates sold 94,251 Evolent Health shares in Q4 2016, an estimated $1.86M.
Evolent Health made up 1.1% of Wall Street Associates's portfolio in Q4 2016, its #17 holding.
Wall Street Associates first reported a position in Evolent Health in Q2 2015 and has held it in 7 quarters since.
Wall Street Associates's Evolent Health position peaked at $7.13M in Q2 2015.
118 funds tracked by Wall St. Rank held Evolent Health as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.